AnalystsSean Laaman
Sean Laaman's Stock Forecasts

Analyst Ranking
Top 26%
#1429 out of 5544 analysts
Average Return
+5.7%
Win Rate
56%18 out of 32
Risk vs Reward
Poor
Good

Sean Laaman's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Resmed IncRMD
+90.17%$134.65$256.07
2023-10-27 -
2024-10-25
Strong Buy
Beone Medicines LtdONC
+60.28%$206.01$330.19
2024-12-03 -
2025-12-02
Strong Buy
Axsome Therapeutics IncAXSM
+58.91%$105.44$167.55
2025-07-03 -
2026-01-08
Strong Buy
Disc Medicine IncIRON
+39.29%$54.75$76.26
2025-07-03 -
2026-07-02
Strong Buy
Halozyme Therapeutics IncHALO
+36.28%$58.29$79.44
2025-02-14 -
2026-02-13
Strong Buy

Sean Laaman's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Alector IncALEC
2Strong Sell$3.00+53.85%Maintains
14 days ago
Enliven Therapeutics IncELVN
1Strong Buy$70.00+80.88%Initiates Coverage On
18 days ago
Axsome Therapeutics IncAXSM
7Hold$247.00+58.53%Maintains
25 days ago
Revolution Medicines IncRVMD
1Strong Buy$255.00+39.99%Initiates Coverage On
a month ago
Argenx SeARGX
2Strong Buy$1,250.00+51.40%Maintains
2 months ago
Bridgebio Pharma IncBBIO
3Strong Buy$97.00+42.77%Maintains
2 months ago
Maplight Therapeutics IncMPLT
2Hold$21.00+162.50%Downgrades
3 months ago
Exelixis IncEXEL
8Hold$53.00-15.44%Maintains
3 months ago
Erasca IncERAS
1Hold$21.00+54.19%Maintains
3 months ago
Disc Medicine IncIRON
5Strong Buy$85.00+7.69%Maintains
4 months ago
Generate Biomedicines IncGENB
2Strong Buy$22.00+75.16%Maintains
5 months ago
Certara IncCERT
3Hold$10.00+5.82%Maintains
5 months ago
Eikon Therapeutics IncEIKN
1Strong Buy$32.00+315.58%Initiates Coverage On
8 months ago
Bridgebio Oncology Therapeutics IncBBOT
1Strong Buy$20.00+601.75%Initiates Coverage On
10 months ago
Resmed IncRMD
2Strong Buy$304.00+26.79%Maintains
a year ago
Beone Medicines LtdONC
3Strong Buy$383.00+3.47%Maintains
a year ago
Halozyme Therapeutics IncHALO
1Strong Buy$67.00N/AAssumes
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.